DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th.
This year, Biosense Webster, Inc. will be showcasing its cutting edge product pipeline and constant innovation. Over the past few months, the company has launched significant products and ground breaking innovations into the Electrophysiology marketplace, with the most recent being the European release of the new ThermoCool(R)SF catheter. In the past few months, the company has launched its pioneering new 3D mapping platform, the Carto(R) 3 System and NaviStar(R) and Celsius(R) RMT ThermoCool(R) Catheters around the globe.
"We are gaining significant momentum with our Carto(R) 3 system around the world," said Shlomi Nachman, President, Biosense Webster. "Our installed base is ramping up extremely quickly with EP labs across the globe". "We are looking forward to unleashing the true blockbuster potential of the Carto(R) 3 System as more and more labs switch over to the new Carto(R) System platform and many upgrade from their current Carto(R) XP System.
"The Carto(R) 3 System is an exciting technology that represents a major
step forward for electrophysiologists. I was especially impressed with the
Fast Anatomical Mapping [FAM] feature with the Lasso(R) NAV Circular Variable
Mapping Catheter. I was able to create a map quickly and the accuracy was
excellent," said '/>"/>
|SOURCE Biosense Webster, Inc.|
Copyright©2010 PR Newswire.
All rights reserved